Aerovate Therapeutics Inc AVTE.O:
AEROVATE THERAPEUTICS DECLARES SPECIAL CASH DIVIDEND IN CONNECTION WITH THE PROPOSED MERGER WITH JADE BIOSCIENCES
AEROVATE THERAPEUTICS INC: AGGREGATE CASH DIVIDEND OF $69.6 MILLION, OR AN ESTIMATED $2.40 PER SHARE
AEROVATE THERAPEUTICS INC: CASH DIVIDEND WILL BE AN AGGREGATE OF $69.6 MILLION, OR AN ESTIMATED $2.40 PER SHARE
Source text: ID:nPnby2f62a
Further company coverage: AVTE.O
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。